The Global Influenza Drugs and Vaccines Market 2016 – 2021 new report by ReportsnReports says rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

According to research report, "Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) – Analysis By Region, By Country: Opportunities and Forecast (2016-2021) – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)", global market is projected to display a steady growth rate represented by a CAGR of 10.24 per cent during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.

The report has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.